Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

Patrick A. Ott,Jason L. Chang,Ruth Oratz,Amanda Jones,K. Farrell,Franco M. Muggia,Anna C. Pavlick

Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

2009

Patrick A. Ott
Jason L. Chang
Ruth Oratz
Amanda Jones
K. Farrell
Franco M. Muggia
Anna C. Pavlick

Objective: This phase II study evaluated the efficacy and tolerability of dacarbazine in combination with thalidomide in metastatic melanoma patients. Methods: Ch

Keywords:

Immunology
Adjuvant therapy
Melanoma
Peripheral neuropathy
Thalidomide
Biology
Phases of clinical research
Progressive disease
Dacarbazine
Tolerability
metastatic melanoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations